Actuate Therapeutics Inc (NASDAQ:ACTU)’s traded shares stood at 53976.0 during the last session. At the close of trading, the stock’s price was $6.59, to imply a decrease of -2.23% or -$0.15 in intraday trading. The ACTU share’s 52-week high remains $11.99, putting it -81.94% down since that peak but still an impressive 16.54% since price per share fell to its 52-week low of $5.50. The company has a valuation of $132.24M, with an average of 0.25 million shares in intraday trading volume over the past 10 days and average of 92.85K shares over the past 3 months.
Actuate Therapeutics Inc (NASDAQ:ACTU) trade information
After registering a -2.23% downside in the last session, Actuate Therapeutics Inc (ACTU) has traded red over the past five days. The 5-day price performance for the stock is 13.23%, and -32.41% over 30 days. Short interest in Actuate Therapeutics Inc (NASDAQ:ACTU) saw shorts transact 0.24 million shares and set a 3.74 days time to cover.
The extremes give us $21 and $21 for target low and target high price respectively. As such, ACTU has been trading -218.66% off suggested target high and -218.66% from its likely low.
ACTU Dividends
Actuate Therapeutics Inc has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Actuate Therapeutics Inc (NASDAQ:ACTU)’s Major holders
Actuate Therapeutics Inc insiders hold 18.94% of total outstanding shares, with institutional holders owning 53.53% of the shares at 66.04% float percentage. In total, 53.53% institutions holds shares in the company.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Northern Funds-SMALL CAP CORE FUND as the top two Mutual Funds with the largest holdings of the Actuate Therapeutics Inc (ACTU) shares. Going by data provided on Apr 30, 2025, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 16.78 shares. This is just over 0.09% of the total shares, with a market valuation of $0.11 million. Data from the same date shows that the other fund manager holds a little less at 15.8, or 0.08% of the shares, all valued at about 0.1 million.
